LIFECORE BIOMEDICAL INC (LFCR) Stock Price, Forecast & Analysis
NASDAQ:LFCR • US5147661046
LFCR Key Statistics, Chart & Performance
The current stock price of LFCR is 7.13 USD. In the past month the price decreased by -17%. In the past year, price increased by 27.09%.
LFCR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to LFCR. When comparing the yearly performance of all stocks, LFCR turns out to be only a medium performer in the overall market: it outperformed 62.09% of all stocks.
LFCR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to LFCR. Both the profitability and financial health of LFCR have multiple concerns.
LFCR Financial Highlights
Over the last trailing twelve months LFCR reported a non-GAAP Earnings per Share(EPS) of -1.07. The EPS decreased by -2114.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -16.6% | ||
| ROE | -106.13% | ||
| Debt/Equity | 3.67 |
LFCR Forecast & Estimates
11 analysts have analysed LFCR and the average price target is 8.93 USD. This implies a price increase of 25.18% is expected in the next year compared to the current price of 7.13.
For the next year, analysts expect an EPS growth of 36.35% and a revenue growth 1.62% for LFCR
LFCR Ownership
LFCR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.58 | 191.962B | ||
| DHR | DANAHER CORP | 24.67 | 148.096B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 139.57 | 46.374B | ||
| A | AGILENT TECHNOLOGIES INC | 20.3 | 34.761B | ||
| IQV | IQVIA HOLDINGS INC | 12.66 | 28.089B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.8 | 28.006B | ||
| WAT | WATERS CORP | 23.04 | 19.843B | ||
| ILMN | ILLUMINA INC | 22.73 | 17.98B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 30.72 | 17.346B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.99 | 12.783B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About LFCR
Company Profile
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. The company is headquartered in Chaska, Minnesota and currently employs 406 full-time employees. The firm designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The firm offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. The company is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The firm uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
Company Info
LIFECORE BIOMEDICAL INC
3515 Lyman Boulevard
Chaska MINNESOTA US
Employees: 406
Phone: 19523684300
LIFECORE BIOMEDICAL INC / LFCR FAQ
What does LFCR do?
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. The company is headquartered in Chaska, Minnesota and currently employs 406 full-time employees. The firm designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The firm offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. The company is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The firm uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
Can you provide the latest stock price for LIFECORE BIOMEDICAL INC?
The current stock price of LFCR is 7.13 USD. The price decreased by -0.97% in the last trading session.
What is the dividend status of LIFECORE BIOMEDICAL INC?
LFCR does not pay a dividend.
What is the ChartMill rating of LIFECORE BIOMEDICAL INC stock?
LFCR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists LFCR stock?
LFCR stock is listed on the Nasdaq exchange.
What is the expected growth for LFCR stock?
The Revenue of LIFECORE BIOMEDICAL INC (LFCR) is expected to grow by 1.62% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is LIFECORE BIOMEDICAL INC worth?
LIFECORE BIOMEDICAL INC (LFCR) has a market capitalization of 267.16M USD. This makes LFCR a Micro Cap stock.